Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Senores Pharmaceuticals Limited
Location
T. Score
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
People
Network
Registered Details

SENORES PHARMACEUTICALS LIMITED

Active

Updated: 21 Oct 2024

Senores Pharmaceuticals Limited, is an unlisted public company incorporated on 26 December, 2017. It is classified as a public limited company and is located in Ahmedabad, Gujarat. It's authorized share capital is INR 59.00 cr and the total paid-up capital is INR 33.27 cr.

Senores Pharmaceuticals Limited's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 253.88% over the previous year. At the same time, it's book networth has increased by 13.37%.

Industry

Manufacturing of Pharmaceuticals

Products

Pharmaceutical products, Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Total Revenue

133.24%

₹ GET PRO

EBITDA

₹ GET PRO

Net Profit

-55.57%

₹ GET PRO

Networth

340.17%

₹ GET PRO

Borrowings

57.22%

₹ GET PRO

Assets

178.54%

₹ GET PRO

Gross Margin

-18.94

GET PRO %

Operating Margin

16.92

GET PRO %

Net Profit Margin

-8.47

GET PRO %

Return on Equity

-4.32

GET PRO %

ROCE

1.95

GET PRO %

Debt to Equity

-0.99

GET PRO

Sales

Mar 2024

Net worth

Mar 2024

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

View subscriptions and buy credits

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
- Litigation and more
Due diligence report

₹ 2999
- Everything in financial report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

Locations

India (3)

State	Type	Address

Locations on Map

Tofler Score

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

No risks identified

Low Risk

No risks identified

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Financial Highlights

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Gross margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Networth
Borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Debt to equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ROE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
WC days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2022	Mar 2023	Mar 2024
Equity Capital	8.7	9.8	30.5
Reserves	28.2	35.0	201.2
Borrowings +	14.2	60.8	248.4
Long term borrowings	12.2	28.7	133.7
Short term borrowings	2.0	32.0	114.7
Trade payables +	7.1	13.6	113.0
Days payable	324.0	391.0	389.0
Other liabilities +	8.4	23.2	141.8
Other non-current liabilities	0.5	1.8	9.0
Other current liabilities	0.8	7.8	19.8
Total liabilities	59.5	128.9	621.9
Fixed Assets +	15.0	59.3	332.5
Tangible assets	5.8	7.2	161.3
CWIP	8.1	35.7	97.1
Intangible assets	1.1	16.4	74.1
LT loans and advances	1.0	-	-
Other non-current assets	16.1	18.1	38.5
Current assets +	27.3	51.3	250.9
Inventories	3.0	3.1	37.4
Trade receivables	19.9	22.1	112.0
Cash and cash equivalents	3.2	0.1	13.1
ST loans and advances	-	0.5	0.3
Other current assets	1.2	25.5	88.1
Total assets	59.5	128.9	621.9

Percentage of assets	Mar 2022	Mar 2023	Mar 2024
Equity Capital	14.7	7.62	4.91
Reserves	47.36	27.19	32.35
Borrowings +	23.89	47.16	39.94
Long term borrowings	20.54	22.29	21.49
Short term borrowings	3.35	24.86	18.45
Trade payables	12.0	10.54	18.17
Other liabilities +	14.05	18.04	22.8
Other non-current liabilities	0.77	1.43	1.45
Other current liabilities	1.28	6.07	3.18
Total liabilities
Fixed Assets +	25.23	46.04	53.47
Tangible assets	9.7	5.6	25.94
CWIP	13.63	27.7	15.61
Intangible assets	1.89	12.75	11.91
LT loans and advances	1.74	0.08	0.0
Other non-current assets	27.08	14.04	6.19
Current assets +	45.95	39.84	40.35
Inventories	5.02	2.43	6.01
Trade receivables	33.47	17.16	18.01
Cash and cash equivalents	5.41	0.08	2.1
ST loans and advances	0.0	0.42	0.05
Other current assets	2.06	19.76	14.17
Total assets

Total assets

Profit & Loss

Standalone

Consolidated

₹

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Sales growth %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Expenses +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cost of goods	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Employee cost	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other costs	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other income	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Depreciation	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Exceptional items	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit before tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit - disc. ops	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Precentage of total income	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Expenses +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cost of goods	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Employee cost	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other costs	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other income	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Depreciation	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Exceptional items	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit before tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit - disc. ops	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2022	Mar 2023	Mar 2024
Sales +	14.2	35.3	214.5
Sales growth %	None	149.47	507.09
Expenses +	13.5	31.1	192.4
Cost of goods	8.0	12.7	106.1
Employee cost	2.9	4.8	35.5
Other costs	1.3	5.2	31.3
Operating profit +	1.9	12.7	41.6
Operating margin %	13.7	35.9	19.4
Other income	0.7	3.7	2.8
Interest	0.6	2.4	9.4
Depreciation	0.7	6.0	10.0
Exceptional items	-	-	-
Profit before tax	1.4	7.9	24.9
Tax	0.2	2.3	-7.8
Profit - disc. ops	-	-	-
Net profit	1.3	5.6	32.7
Net margin %	8.4	14.3	15.1

Precentage of total income	Mar 2022	Mar 2023	Mar 2024
Sales	95.1	90.56	98.7
Expenses +	90.56	79.7	88.52
Cost of goods	53.93	32.5	48.83
Employee cost	19.21	12.28	16.31
Other costs	8.89	13.31	14.42
Operating profit	13.07	32.47	19.14
Other income	4.9	9.44	1.3
Interest	3.79	6.21	4.35
Depreciation	4.73	15.41	4.61
Exceptional items	0.0	0.0	0.0
Profit before tax	9.44	20.3	11.48
Tax	1.02	6.0	-3.57
Profit - disc. ops	0.0	0.0	0.0
Net profit	8.42	14.29	15.05

Revenue from operations

Ratios

Standalone

Consolidated

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net Debt/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Debt/Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Assets/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Liquidity +
Current Ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Quick Ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest Coverage	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Performance
Gross Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Return +
Return on Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Pre-tax ROCE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Return on Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Pre-tax ROIC	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Efficiency +
Days Payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days Inventory	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days Receivable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Asset Turnover	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Asset Turnover	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Working Capital
Cash Conversion Cycle	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Working Capital Days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2022	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	0.4	1.4	1.1
Net Debt/Equity	0.3	1.4	1.0
Total Debt/Assets	0.2	0.5	0.4
Total Assets/Equity	1.6	2.9	2.7
Liquidity +
Current Ratio	2.8	1.0	1.0
Quick Ratio	2.5	0.9	0.9
Interest Coverage	3.4	5.2	4.4
Performance
Gross Margin	43.3	64.1	50.5
Operating Margin	13.7	35.9	19.4
Net Margin	8.4	14.3	15.1
Return +
Return on Equity	3.4	12.4	14.1
Pre-tax ROCE	3.8	11.6	9.4
Return on Assets	2.1	4.3	5.3
Pre-tax ROIC	2.6	6.3	6.8
Efficiency +
Days Payable	324.0	391.0	389.0
Days Inventory	136.0	90.0	129.0
Days Receivable	513.0	228.0	191.0
Fixed Asset Turnover	0.9	0.6	0.7
Total Asset Turnover	0.2	0.3	0.3
Working Capital
Cash Conversion Cycle	325.0	-73.0	-69.0
Working Capital Days	449.0	-22.0	6.0

Ratios

Current ratio

Debt/equity ratio

Charges on assets

Bank wise

Charges

HDFC Bank Limited

No. of Loans: 3

Total Amount : 147.7 cr

ICICI Bank Limited

No. of Loans: 2

Total Amount : 48.5 cr

Charge Holder	Amount	Date of creation/modification
ICICI Bank Limited	43.5 cr	05 Oct, 2024
ICICI Bank Limited	5.0 cr	26 Sep, 2024
HDFC Bank Limited	70.5 cr	28 Jun, 2024
HDFC Bank Limited	37.2 cr	12 Jan, 2024
HDFC Bank Limited	40.0 cr	23 Jun, 2023

Charges

HDFC Bank Limited

ICICI Bank Limited

People

Designation	Name	DIN/PAN	Tenure
Director	Sanjay Shaileshbhai Majmudar	00091305	1 years
Director	Jitendra Babulal Sanghvi	00271995	3 years
Director	Manjula Devi Shroff	00297159	1 years
Director	Deval Rajnikant Shah Shareholder	00332722	5 years
Kmp	Deval Rajnikant Shah	<HIDDEN>	1 years
Director	Ashokbhai Vijaysinh Barot Shareholder	01192300	7 years
Director	Udayan Dileep Choksi	02222020	1 years
Director	Kalpit Rajesh Gandhi	02843308	1 years
Managing Director	Swapnil Jatinbhai Shah Shareholder	05259821	4 years
Director	Arpit Deepakkumar Shah	07214641	2 years
Director	Chetan Bipinchandra Shah	10381971	2 years
Director	Hemanshu Nitinchandra Pandya	10383995	2 years
Director	Naresh Bansilal Shah	10384306	1 years
Kmp	Nidhi Dilipbhai Kapadia	<HIDDEN>	2 years

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
WELCAST STEELS LIMITED	Active	63.8 L	1	Gujarat
DISHMAN PHARMACEUTICALS AND CHEMICALS LIMITED	Amalgamated	32.3 Cr	1	Gujarat
KEYUR FINANCIAL SERVICES PRIVATE LIMITED	Amalgamated	2.3 Cr	1	Gujarat
ASHIMA LIMITED	Active	212.2 Cr	1	Gujarat
M & B ENGINEERING LIMITED	Active	50.0 Cr	2	Gujarat
AIA ENGINEERING LIMITED	Active	18.7 Cr	1	Gujarat
RATNAMANI FOOD PRODUCTS PRIVATE LIMITED	Amalgamated	50.0 L	1	Gujarat
RAMAYA ESTATE DEVELOPERS PRIVATE LIMITED	Strike Off	1.0 L	1	Gujarat
RATNAMANI HOLDINGS PRIVATE LIMITED	Amalgamated	43.0 L	1	Gujarat
RATNATRIS PHARMACEUTICALS PRIVATE LIMITED	Active	3.7 Cr	5	Gujarat
HENERY TRADECOM PRIVATE LIMITED	Active	1.0 L	1	Delhi
SMART GUARD SYSTEMS PRIVATE LIMITED	Amalgamated	5.0 L	1	Gujarat
GUJARAT GAS COMPANY LIMITED	Amalgamated	25.6 Cr	1	Gujarat
SCHOOLS WELFARE FEDERATION	Active	0.0	1	Gujarat
E-INFOCHIPS BANGALORE LIMITED	Amalgamated	5.0 L	1	Gujarat
SURANGI SERVICES LIMITED	Active	4.2 Cr	1	Delhi
E-INFOCHIPS INSTITUTE OF TRAINING RESEARCH AND ACADEMICS	Active	5.0 L	1	Gujarat
C3PO AVIONICS PRIVATE LIMITED	Strike Off	1.0 L	1	Gujarat
ALTUS LEARNING PRIVATE LIMITED	Active	79.7 L	1	Delhi
ALLEN ENTERPRISES PRIVATE LIMITED	Active	10.5 L	1	Delhi
EIMCO ELECON (INDIA ) LIMITED	Active	5.8 Cr	1	Gujarat
RATNAGENE LIFESCIENCE PRIVATE LIMITED	Amalgamated	6.9 Cr	3	Gujarat
DI- CAL PHARMA PRIVATE LIMITED	Active	25.0 L	1	Gujarat
TIERRA FERTILIZER PRIVATE LIMITED	Active	2.0 Cr	1	Gujarat
AVIRAJ CHARITABLE FOUNDATION	Active	1.0 L	1	Gujarat
AVIRAJ VENTURES LLP	Active	2.8 Cr	1	Gujarat
UNIVERSAL TRUSTEES PRIVATE LIMITED	Active	5.0 Cr	1	Maharashtra
APCOTEX INDUSTRIES LIMITED	Active	10.4 Cr	1	Maharashtra
BHAVNAGAR PORT INFRASTRUCTURE PRIVATE LIMITED	Active	50.0 Cr	1	Gujarat
VADILAL MARKETING PVT LTD	Active	7.4 L	1	Gujarat
VADILAL INTERNATIONAL PRIVATE LIMITED	Active	15.0 L	1	Gujarat
VADILAL DELIGHTS LIMITED	Active	5.0 L	1	Gujarat
KARMAN DEVELOPERS LLP	Active	20,000.0	1	Gujarat
VADILAL INDUSTRIES LIMITED	Active	7.2 Cr	1	Gujarat
RELIUS LIFESCIENCES PRIVATE LIMITED	Active	1.0 L	2	Gujarat
RENOSEN PHARMACEUTICALS PRIVATE LIMITED	Active	1.0 L	1	Gujarat
SUMER ENTERPRISES LLP	Active	1.0 L	2	Gujarat
ESPEE THERAPEUTICS LLP	Active	1.0 Cr	1	Gujarat
AELIUS PROJECTS LLP	Active	10.0 L	1	Gujarat
REMUS PHARMACEUTICALS LIMITED	Active	5.9 Cr	2	Gujarat

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
RATNATRIS PHARMACEUTICALS PRIVATE LIMITED	Gujarat	2005	₹ 3.7 Cr
Havix Group Inc	United States	-	-
Senores Pharmaceuticals INC	United States	-	-

Registered Details

CIN

U24290GJ2017PLC100263

PAN

AAZCS6422N

Incorporation

2017, 7.4 years

Company Email

legal@senorespharma.com

Paid up Capital

₹ 33.3 Cr

Authorised Capital

₹ 59.0 Cr

AGM

Sep 2023

Type

Public

Non-government Company

FAQ - SENORES PHARMACEUTICALS LIMITED

What is the incorporation date of SENORES PHARMACEUTICALS LIMITED?

The incorporation date of SENORES PHARMACEUTICALS LIMITED is 26 December, 2017

What is the authorized share capital of SENORES PHARMACEUTICALS LIMITED?

The authorized share capital of SENORES PHARMACEUTICALS LIMITED is INR ₹ 59.0 Cr.

What is the paid-up capital of SENORES PHARMACEUTICALS LIMITED?

The paid-up capital of SENORES PHARMACEUTICALS LIMITED is INR ₹ 33.3 Cr.

What is the registered address of SENORES PHARMACEUTICALS LIMITED?

The registered address of SENORES PHARMACEUTICALS LIMITED is 1101 to 1103, 11th floor, South Tower, ONE 42 Opp. Jayanti lal Park, Ambali Bopal Road, NA Ahmedabad Ahmedabad Gujarat - 380054

What is the CIN number of SENORES PHARMACEUTICALS LIMITED?

The CIN number of SENORES PHARMACEUTICALS LIMITED is U24290GJ2017PLC100263.

Smart Suggestions

Uttar Pradesh
Haryana
Jammu & Kashmir
Punjab
Goa
Madhya Pradesh
Kerala
Gujarat
Andhra Pradesh
Telangana
Blog Categories
Top Blog post
Financial Resources

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

SENORES PHARMACEUTICALS LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Industry

Buy Report or Plans

Dashboards

Company dashboard

View subscriptions and buy credits

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Due diligence report

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

Tofler Score

Risk

About Tofler Score

Financial Highlights

Margins

Balance Sheet

Total assets

Profit & Loss

Revenue from operations

Ratios

Ratios

Charges on assets

Charges

People

Company Network